Does Keppra Cause Constipation?
Levetiracetam (Keppra) does not cause constipation as a significant adverse effect. According to FDA labeling data, constipation occurred at similar or lower rates in Keppra-treated patients compared to placebo groups in clinical trials 1.
Evidence from FDA Drug Labeling
The official FDA prescribing information for Keppra explicitly lists adverse events that occurred in at least 1% of treated patients and more frequently than placebo. Constipation is notably absent from this list 1. In fact, the FDA label specifically states that constipation was reported "as or more frequent in the placebo group" rather than in the Keppra group 1.
Common Adverse Effects of Keppra
The most frequently reported adverse effects associated with Keppra include 1:
- Somnolence (15-8% vs placebo)
- Asthenia (weakness/fatigue)
- Dizziness (9-4% vs placebo)
- Infection (particularly upper respiratory)
- Behavioral effects (hostility, nervousness, irritability, anxiety)
- Headache
Gastrointestinal Effects
When gastrointestinal effects do occur with Keppra, they typically manifest as 1:
- Diarrhea (8-7% in some studies)
- Nausea
- Vomiting
- Anorexia (3-2% vs placebo)
These effects are generally opposite to constipation.
Research Evidence Confirms Low Constipation Risk
A comprehensive systematic review of Keppra's safety profile analyzing 3,347 patients found that the predominant adverse effects were somnolence, asthenia, and dizziness, with no mention of constipation as a significant concern 2. Another detailed adverse effects analysis specifically examining less common side effects also did not identify constipation as statistically significant 3.
In a recent pediatric study comparing Keppra to modified Atkins diet, constipation was reported in 41.1% of patients on the diet but was not reported as an adverse effect in the Keppra group 4, further supporting that constipation is not associated with levetiracetam use.
Clinical Implications
- Keppra is not a constipating medication and should not be avoided in patients prone to constipation
- If a patient on Keppra develops constipation, look for other causes (other medications, underlying conditions, dietary factors)
- Keppra may actually be preferable to some older antiepileptic drugs that do cause constipation
- The medication has a favorable gastrointestinal tolerability profile overall
Important Caveat
While behavioral side effects (irritability, anxiety, hostility) occur in 2-12% of patients depending on the specific symptom 1, these psychiatric effects should not be confused with gastrointestinal symptoms. The drug is generally well-tolerated from a GI perspective.